Chiral Intranasal Nanovaccines as Antivirals for Respiratory Syncytial Virus
Adv Mater. 2024 Sep 2:e2408090. doi: 10.1002/adma.202408090. Online ahead of print. ABSTRACT This study aimed to develop an intranasal nanovaccine by combining chiral nanoparticles with …